TABLE 5.
Vergence/Accommodative % (95% CI) |
Placebo % (95% CI) |
|
---|---|---|
Time Point | Normal Accommodative Amplitude † | |
Week 4 | 47% (37% to 56%) | 19% (10% to 30%) |
Week 8 | 58% (49% to 68%) | 23% (13% to 35%) |
Week 12 | 63% (53% to 72%) | 35% (24% to 48%) |
Week 16 | 69% (59% to 77%) | 32% (21% to 45%) |
Time Point | Normal Accommodative Facility ‡ | |
Week 4 | 36% (25% to 49%) | 14% (5% to 29%) |
Week 8 | 68% (56% to 79%) | 39% (23% to 57%) |
Week 12 | 87% (77% to 94%) | 35% (20% to 53%) |
Week 16 | 85% (74% to 93%) | 49% (32% to 66%) |
Normal accommodative amplitude defined as amplitude ≥ 14 diopters.
Normal accommodative facility defined as facility ≥ 11 cycles per minute.
95% CI = confidence interval.